(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) slid by a staggering 29.74% in 21 sessions from €1.22 to €0.86 at 19:10 EST on Tuesday, after five consecutive sessions in a row of losses. BEL 20 is jumping 1.49% to €3,685.24, following the last session’s upward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a…
(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are FINATIS, CNOVA, and CELYAD ONCOLOGY. Financial Asset Price Change Updated (EST) FINATIS (FNTS.PA) 9.45 18.12% 2023-03-20 11:49:51 CNOVA (CNV.PA) 4.71 13.49% 2023-03-20 11:46:29 CELYAD ONCOLOGY…
(VIANEWS) – The Market ended the session with CELYAD ONCOLOGY (CYAD.BR) jumping 10.76% to €0.84 on Monday while BEL 20 jumped 0.78% to €3,630.99. About CELYAD ONCOLOGY Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) rose by a staggering 10.76% to €0.84 at 10:10 EST on Monday, after five consecutive sessions in a row of losses. BEL 20 is dropping 1.76% to €3,539.30, following the last session’s downward trend. This seems, so far, an all-around bearish trend trading session today. About…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) slid by a staggering 11.76% to €0.75 at 10:11 EST on Thursday, after three sequential sessions in a row of losses. BEL 20 is rising 0.89% to €3,662.18, after five sequential sessions in a row of losses. This seems, up until now, a somewhat positive trend…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) dropped by a staggering 27.1% in 21 sessions from €1.36 to €0.99 at 16:09 EST on Tuesday, after two sequential sessions in a row of losses. BEL 20 is rising 2.14% to €3,738.34, after five sequential sessions in a row of losses. About CELYAD ONCOLOGY Celyad…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) dropped by a staggering 20.33% in 10 sessions from €1.23 to €0.98 at 16:09 EST on Monday, after five consecutive sessions in a row of losses. BEL 20 is rising 0.14% to €3,890.68, following the last session’s upward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) dropped by a staggering 34.41% in 21 sessions from €1.74 to €1.14 at 13:11 EST on Wednesday, following the last session’s upward trend. BEL 20 is dropping 0.91% to €3,865.79, following the last session’s downward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a clinical-stage biopharmaceutical company,…
